Stanford Cancer Institute Palo Alto — Palo Alto, California

Stanford Cancer Institute Palo Alto is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute Palo Alto has participated in 196 clinical trials with 120 currently active.

Therapeutic areas: Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma.

Sponsors: Andrei Iagaru, Children's Oncology Group, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute Palo Alto?

Stanford Cancer Institute Palo Alto has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute Palo Alto conducted?

Stanford Cancer Institute Palo Alto has 196 clinical trials on record, with 120 currently active. Their work covers Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma.

Is Stanford Cancer Institute Palo Alto accredited by Crixeo Health?

Stanford Cancer Institute Palo Alto has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute Palo Alto?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.